EP2040746A4 - Procedes de recuperation de formules stabilisees de trimeres de proteines d'enveloppe (env) retrovirale - Google Patents

Procedes de recuperation de formules stabilisees de trimeres de proteines d'enveloppe (env) retrovirale

Info

Publication number
EP2040746A4
EP2040746A4 EP07809720A EP07809720A EP2040746A4 EP 2040746 A4 EP2040746 A4 EP 2040746A4 EP 07809720 A EP07809720 A EP 07809720A EP 07809720 A EP07809720 A EP 07809720A EP 2040746 A4 EP2040746 A4 EP 2040746A4
Authority
EP
European Patent Office
Prior art keywords
trimerer
wrapper
retroviral
formulations
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07809720A
Other languages
German (de)
English (en)
Other versions
EP2040746A1 (fr
Inventor
William C Olson
Paul J Maddon
Michael Franti
Sai Prasad N Iyer
Yun Kang
John P Moore
Simon Beddows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Progenics Pharmaceuticals Inc
Original Assignee
Cornell Research Foundation Inc
Progenics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc, Progenics Pharmaceuticals Inc filed Critical Cornell Research Foundation Inc
Publication of EP2040746A1 publication Critical patent/EP2040746A1/fr
Publication of EP2040746A4 publication Critical patent/EP2040746A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
EP07809720A 2006-06-19 2007-06-19 Procedes de recuperation de formules stabilisees de trimeres de proteines d'enveloppe (env) retrovirale Withdrawn EP2040746A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81511406P 2006-06-19 2006-06-19
PCT/US2007/014388 WO2007149490A1 (fr) 2006-06-19 2007-06-19 Procédés de récupération de formules stabilisées de trimères de protéines d'enveloppe (env) rétrovirale

Publications (2)

Publication Number Publication Date
EP2040746A1 EP2040746A1 (fr) 2009-04-01
EP2040746A4 true EP2040746A4 (fr) 2009-12-16

Family

ID=38833738

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07809720A Withdrawn EP2040746A4 (fr) 2006-06-19 2007-06-19 Procedes de recuperation de formules stabilisees de trimeres de proteines d'enveloppe (env) retrovirale

Country Status (3)

Country Link
EP (1) EP2040746A4 (fr)
CA (1) CA2655929A1 (fr)
WO (1) WO2007149490A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5813513B2 (ja) 2008-12-09 2015-11-17 ノババックス,インコーポレイテッド 修飾rsvfタンパク質及びその使用方法
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
EP2765138B1 (fr) * 2012-11-05 2018-01-10 International Aids Vaccine Initiative Glycoprotéine d'enveloppe du VIH-1
WO2015171975A1 (fr) * 2014-05-09 2015-11-12 The Regents Of The University Of Michigan Utilisation d'une lectine modifiée de la banane dans la purification de glycoprotéines
EP4494650A3 (fr) 2015-09-03 2025-03-26 Novavax, Inc. Compositions vaccinales ayant une stabilite et une immunogenicite ameliorees
WO2019023196A1 (fr) 2017-07-24 2019-01-31 Novavax, Inc. Méthodes et compositions pour traiter la maladie respiratoire
EP3768308A4 (fr) 2018-03-19 2022-01-26 Novavax, Inc. Vaccins multivalents contre la grippe à base de nanoparticules
JP7170942B1 (ja) * 2019-11-07 2022-11-14 ヤンセン ファッシンズ アンド プリベンション ベーフェー タンパク質精製

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089526A1 (en) * 2001-09-06 2005-04-28 Moore John P. Human immunodeficiency virus envelope clycoprotein mutants and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781676B1 (fr) * 1998-07-31 2004-04-02 Pasteur Merieux Serums Vacc Trimere du produit d'expression du gene env de hiv
AU2004226345B2 (en) * 2003-03-28 2011-12-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services MVA virus expressing modified HIV envelope, gag, and pol genes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089526A1 (en) * 2001-09-06 2005-04-28 Moore John P. Human immunodeficiency virus envelope clycoprotein mutants and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SANDERS R W ET AL: "Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 76, no. 17, 1 September 2002 (2002-09-01), pages 8875 - 8889, XP002393505, ISSN: 0022-538X *
See also references of WO2007149490A1 *

Also Published As

Publication number Publication date
CA2655929A1 (fr) 2007-12-27
EP2040746A1 (fr) 2009-04-01
WO2007149490A1 (fr) 2007-12-27

Similar Documents

Publication Publication Date Title
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATE538111T1 (de) Verfahren zur synthese von 5- alkoxymethylfurfuralethern
EP1748077A4 (fr) Procédé consistant à produire une protéine
DE602007011843D1 (de) Verfahren zur Herstellung von Gruppe-III-Nitridkristallen
DK2061803T4 (da) Fremgangsmåde til oprensning af fc-holdige proteiner
EP1984384A4 (fr) Analogues de conotoxine, et procédé de synthèse de peptides contenant des ponts dicarba intramoléculaires
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
ATE459416T1 (de) Verfahren zur beseitigung von endokrin wirksamen verbindungen
PT2001312E (pt) Método de preparação de uma bebida de proteínas
DE602007007400D1 (de) Verfahren zur Niveauregulierung
EP2040746A4 (fr) Procedes de recuperation de formules stabilisees de trimeres de proteines d'enveloppe (env) retrovirale
EP2055677A4 (fr) PROCÉDÉ DE FABRICATION DE SUPRACONDUCTEUR À BASE DE Re (123) SOUS FORME DE RUBAN
DE602007009096D1 (de) Verfahren zur herstellung von benzopyran-2-olderivaten
DE502007003700D1 (de) Verfahren zur Herstellung von Glycerin
DK2080808T3 (da) Fremgangsmåde til fremstilling af l-aminosyre
ATE474845T1 (de) Verfahren zur synthese von saccharose-6-estern
ATE544341T1 (de) Verfahren zur verbesserung des nematoden toleranten bzw. -resistenten pflanzenwachstums
DE602006020089D1 (de) Verfahren zur CVI
DE602006002935D1 (de) Verfahren zur Tonerherstellung
ATE487709T1 (de) Verfahren zur synthese von 5-(methyl-1h-imidazol- 1-yl)-3-(trifluormethyl)benzolamin
DE602007003135D1 (de) Verfahren zur Herstellung von Xylylenediamin
DE502007000875D1 (de) Verfahren zur Herstellung von ß-Ketocarbonyl-funktionellen Organosiliciumverbindungen
DE502005000111D1 (de) Verfahren zur kontinuierlichen Hydrosilylierung
DE502007000339D1 (de) Verfahren zur Herstellung von Urethangruppen aufweisenden Organosiliciumverbindungen
DE502005010287D1 (de) Verfahren zur hydrocyanierung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BEDDOWS, SIMON

Inventor name: MOORE, JOHN P.

Inventor name: KANG, YUN

Inventor name: IYER, SAI PRASAD N.

Inventor name: FRANTI, MICHAEL

Inventor name: MADDON, PAUL J.

Inventor name: OLSON, WILLIAM C.

A4 Supplementary search report drawn up and despatched

Effective date: 20091118

17Q First examination report despatched

Effective date: 20100224

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100707